Medigene AG Statistics

Total Valuation

Medigene AG has a market cap or net worth of GBP 21.44 million. The enterprise value is 11.84 million.

Market Cap	21.44M
Enterprise Value	11.84M

Important Dates

The next estimated earnings date is Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+2.65%
Shares Change (QoQ)	+5.09%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	14.24M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	2.57
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.88
EV / Sales	1.90
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.94

Financial Position

The company has a current ratio of 2.39, with a Debt / Equity ratio of 0.13.

Current Ratio	2.39
Quick Ratio	2.22
Debt / Equity	0.13
Debt / EBITDA	n/a
Debt / FCF	-0.17
Interest Coverage	-28.34

Financial Efficiency

Return on equity (ROE) is -63.93% and return on invested capital (ROIC) is -34.49%.

Return on Equity (ROE)	-63.93%
Return on Assets (ROA)	-27.15%
Return on Invested Capital (ROIC)	-34.49%
Return on Capital Employed (ROCE)	-69.20%
Revenue Per Employee	72,562
Profits Per Employee	-155,268
Employee Count	76
Asset Turnover	0.21
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -39.35% in the last 52 weeks. The beta is 0.92, so Medigene AG's price volatility has been similar to the market average.

Beta (5Y)	0.92
52-Week Price Change	-39.35%
50-Day Moving Average	1.44
200-Day Moving Average	2.95
Relative Strength Index (RSI)	62.54
Average Volume (20 Days)	933

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medigene AG had revenue of GBP 6.31 million and -13.51 million in losses. Loss per share was -1.07.

Revenue	6.31M
Gross Profit	5.05M
Operating Income	-13.07M
Pretax Income	-13.24M
Net Income	-13.51M
EBITDA	-12.53M
EBIT	-13.07M
Loss Per Share	-1.07

Full Income Statement

Balance Sheet

The company has 11.89 million in cash and 2.16 million in debt, giving a net cash position of 9.73 million.

Cash & Cash Equivalents	11.89M
Total Debt	2.16M
Net Cash	9.73M
Net Cash Per Share	n/a
Equity (Book Value)	16.67M
Book Value Per Share	1.13
Working Capital	7.71M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -12.02 million and capital expenditures -526,496, giving a free cash flow of -12.54 million.

Operating Cash Flow	-12.02M
Capital Expenditures	-526,496
Free Cash Flow	-12.54M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 79.94%, with operating and profit margins of -207.04% and -213.98%.

Gross Margin	79.94%
Operating Margin	-207.04%
Pretax Margin	-209.76%
Profit Margin	-213.98%
EBITDA Margin	-198.51%
EBIT Margin	-207.04%
FCF Margin	n/a

Dividends & Yields

Medigene AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.65%
Shareholder Yield	-2.65%
Earnings Yield	-63.00%
FCF Yield	-58.49%

Stock Splits

The last stock split was on August 29, 2024. It was a reverse split with a ratio of 0.5.

Last Split Date	Aug 29, 2024
Split Type	Reverse
Split Ratio	0.5

Scores

Medigene AG has an Altman Z-Score of -22.4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-22.4
Piotroski F-Score	n/a